Has Brandon Erickson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $404,710 in general payments to Brandon Erickson, MD across 393 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brandon Erickson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brandon Erickson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brandon Erickson, MD

Orthopaedic Surgery · Harrison, NYNPI 1598029605

Payments from drug & device makers

$404,710in general payments, 2019–2025

Across 393 payments — averaging $1029.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$389K
Depuy Synthes Products, Inc.$7K
Smith+Nephew$4K
Gotham Surgical Solutions & Devices, Inc.$1K
Stryker$750
Johnson & Johnson$736
plus $2K from 13 others

$19,888in research payments, 2019–2025

Across 2 payments — averaging $9944.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$20K

What the payments were for

Consulting fees$154,44640%
Speaking & faculty fees$204,53552%
Travel & lodging$20,3925%
Food & beverage$7,3122%
Education$3,9491%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	328	$388,891
Depuy Synthes Products, Inc.	5	$6,531
Smith+Nephew	11	$4,220
Gotham Surgical Solutions & Devices, Inc.	8	$1,416
Stryker(2 entities)	8	$750
Johnson & Johnson	11	$736
Pinnacle, Inc	1	$557
Suvon Surgical LLC	4	$520
Joint Restoration Foundation, Inc.	1	$289
Liberty Surgical Inc.	1	$150
Acumed LLC	1	$149
Vericel Corporation	2	$141
Bioventus LLC	3	$103
Zimmer Biomet	2	$82
Exactech, Inc.	1	$59
Axogen	2	$47
Medical Device Business Services, Inc.	2	$36
Pacira Pharmaceuticals Incorporated	1	$21
Ferring Pharmaceuticals Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RIGIDLOOP$6,510
HEALIX$4,575
VISUALIZATION$4,575
Bone Anchors with Arthroscopic Delivery System$3,888
Healicoil$3,300
Bioinductive Implant with Arthroscopic Delivery System - Medium$3,300
HEALIX KNOTLESS PEEK$2,167
FMS Duo$1,935
ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE UNIVERS$1,250
BLUEPRINT PSI SYSTEM$269
ORTHOVISC$237
ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE REVERS$213
SHOULDER IMPLANTS CORKSCREWS KNOTLESS$213
ALPHAVENT$172
Clavicle Plating System$149
LENS 4K$139
SPATIAL FRAME$139
DYNACORD$124
MONOVISC$113
ADAPT$111

How this compares

$404,710 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$270,285

Medicare patients

421

Services billed

5,051

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	31	$367
Diclofenac Sodium	20	$322
Methylprednisolone	27	$193
Meloxicam	55	$132
Amoxicillin	17	$9

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Harrison

Anthony RomeoNew York$27M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$14.1M
William RicciNew York$11.6M
Steven HaasNew York$11.5M
Giles ScuderiNew York$10.9M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →